May 2020
Financial Advisor to Histogen, Inc. on its merger with Conatus Pharmaceuticals
Financial Advisor to Neuronetics on its Announced Merger with Greenbrook TMS
Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
Exclusive Financial Advisor (Buy side)
